Shockwave Therapy for Plantar Fasciitis: What the Trials Show

The first step out of bed tells the whole story. For someone with plantar fasciitis, that step lands like a nail through the heel, sharp, specific, and gone again by the time the coffee is brewed. Then it comes back after every long meeting, every parked-far-away errand, every attempt to jog again.

By the time most people start googling shockwave therapy, they’ve already been through the greatest hits: the frozen water bottle, the tennis ball, the night splint gathering dust under the bed. What they want now is a straight answer, does aiming acoustic pulses at a sore heel actually do anything, or is it an expensive way to get bruised?

The honest answer sits somewhere between the glowing clinic brochures and the skeptics’ shrugs. There are real randomized trials here, decades of them, and they tell a more interesting story than either side admits.

First, what shockwave therapy actually is

Extracorporeal shockwave therapy, ESWT in the journals, borrows its core idea from lithotripsy, the technology urologists have used since the 1980s to break up kidney stones without surgery. In the mid-1990s, researchers began asking a different question: what happens when you apply much lower-energy acoustic pulses not to a stone, but to stubborn, poorly healing soft tissue?

The answer turned out to be promising enough that in 2000 the U.S. Food and Drug Administration cleared the first shockwave device specifically for chronic plantar fasciitis, heel pain that had persisted for six months or longer despite standard care. That detail matters more than most marketing pages let on. Shockwave was never studied as a first stop; it was designed for the heel that refuses to get better.

During treatment, a clinician presses a handheld applicator against the sore area of the heel and delivers a rapid series of pressure waves, commonly around 2,000 pulses over 15 to 20 minutes. No incision, no anesthesia in most modern protocols, no downtime beyond some soreness. You walk in, you walk out.

Two broad flavors exist. Focused shockwave concentrates energy at a precise depth inside the tissue, like sunlight through a magnifying glass. Radial shockwave spreads pressure outward from the skin surface, shallower and gentler. Both get called “shockwave” at the front desk, but the physics, and, as we’ll see, some of the evidence, differ.

Does shockwave therapy for plantar fasciitis really work?

Mostly yes, for the right patient, and that qualifier is doing real work in the sentence.

Across dozens of randomized controlled trials, shockwave therapy outperforms sham treatment for chronic plantar fasciitis pain, particularly when measured about 12 weeks after the final session. Pooled analyses generally find that somewhere between half and two-thirds of treated patients report a clinically meaningful drop in heel pain, compared with roughly 30 to 45 percent of those who received a convincing fake treatment.

Notice two things in those numbers. The gap between real and sham is genuine and statistically robust: this is not homeopathy with a price tag. But the placebo arm is remarkably busy. Heel pain often improves on its own; Mayo Clinic and other major centers note that the large majority of plantar fasciitis cases resolve within about 10 months with conservative care alone. Any treatment given during that window inherits some of the credit for natural healing.

The research picture also has honest blemishes. Trials vary widely in device type, energy level, number of sessions, and whether local anesthetic was used (an early practice that, counterintuitively, seemed to blunt results). A handful of well-run studies found no advantage over sham at all. When evidence looks like this, positive on balance, inconsistent at the edges, the fair summary is: shockwave probably helps chronic cases, the effect is moderate rather than dramatic, and individual results genuinely vary.

What the strongest trials and meta-analyses show

Strip the field down to its best evidence and a fairly consistent pattern emerges. The table below summarizes what the randomized-trial literature, taken together, supports, and how confident you should be in each claim.

Question	What the trials show	Strength of evidence
Better than sham for chronic heel pain?	Yes, meaningful pain reduction in roughly 50–65% of patients vs. 30–45% with sham at ~12 weeks	Moderate to strong
Improves function (walking, first steps)?	Yes, modestly; functional scores track pain improvement	Moderate
Works for pain under 6 months old?	Unclear, most positive trials enrolled chronic cases only	Weak
Benefit lasts beyond a year?	Follow-up studies suggest responders often maintain gains at 1–2 years	Moderate, fewer studies
One protocol clearly beats others?	No consensus on ideal energy, pulse count, or session number	Weak

The long-term data deserve a highlight, because they answer the fear behind many searches: is this just a temporary numbing? Apparently not. Cohorts followed for one to two years after treatment generally show that people who improved stayed improved, consistent with the theory that shockwave nudges tissue toward actual repair rather than masking pain.

What the trials cannot tell you is whether you will be in the responder group. No blood test or scan reliably predicts it. That uncertainty is worth pricing into your decision, quite literally, as we’ll get to below.

Focused vs. radial shockwave: does the machine matter?

Probably less than the person operating it, but the distinction isn’t trivial.

Focused ESWT generates a true shockwave: a steep, high-pressure pulse that converges at an adjustable depth, typically several centimeters into tissue. It can reach the plantar fascia’s attachment on the heel bone directly, and it’s the technology behind the original FDA clearance and many of the landmark trials.

Radial devices produce a pneumatic pressure wave, technically not a shockwave at all, that is strongest at the skin and fades with depth. Radial machines are cheaper, more widely available, and common in outpatient physical therapy settings, which is why they’re often what “shockwave therapy” means in practice.

Head-to-head comparisons are limited, and both types beat sham in trials. Some analyses hint that focused treatment may edge out radial for deep insertional problems like plantar fasciitis, while radial performs respectably for more superficial targets. The honest conclusion: both are reasonable, neither is clearly superior for heel pain, and the differences between studies (energy settings, session counts, patient selection) muddy any clean verdict.

A practical takeaway for readers comparison-shopping between clinics: ask which type of device is used, how many pulses per session, and how many sessions are planned. A provider who can answer those questions crisply, and who ties the plan to your specific exam findings rather than a one-size package, is telling you something reassuring about the care behind the machine.

How acoustic pulses coax a stubborn heel to heal

The name is misleading. “Plantar fasciitis” ends in -itis, suggesting inflammation, but tissue samples from chronic cases usually show something closer to degeneration: disorganized collagen, thickened fascia, and a sluggish blood supply. Some researchers argue “fasciosis” would be more accurate. That distinction explains why purely anti-inflammatory approaches often disappoint, and why shockwave’s mechanism is at least biologically plausible.

Laboratory and animal studies point to several overlapping effects:

• Controlled microtrauma. The pressure waves create tiny, deliberate stress in the tissue, essentially restarting a stalled healing response: a wake-up call to a repair process that gave up months ago.
• New blood vessel growth. Studies show shockwave stimulates the release of growth factors that promote neovascularization, improving oxygen and nutrient delivery to a notoriously poorly perfused region.
• Cellular signaling. Mechanical force gets translated into biochemical signals, a process called mechanotransduction, that increases collagen production and encourages fibers to reorganize along lines of stress.
• Pain modulation. High-energy pulses appear to overstimulate local nerve endings and may deplete pain-signaling chemicals in the treated area, which likely explains why some relief shows up before structural change plausibly could.

None of this is fully proven in living human heels, mechanism studies mostly come from lab models, but it hangs together. Shockwave isn’t claiming to add anything to the body. It’s claiming to provoke the body into finishing a job it started and abandoned. That’s a modest claim, and modest claims tend to age better.

What a session actually feels like

Let’s not sugarcoat it: shockwave on a tender heel is uncomfortable. Patients describe it as a rapid snapping or deep tapping sensation, somewhere between a rubber band flick and a small jackhammer, repeated a couple of thousand times over 15 to 20 minutes. On a genuinely inflamed heel, portions of the session can make you grip the table.

The good news is that discomfort is adjustable. Clinicians typically start at lower energy and ramp up to what you can tolerate, and tolerance improves noticeably by the second and third sessions, partly because the heel is already less tender. Most modern protocols skip numbing injections entirely, and not just for comfort logistics: several studies found that anesthetizing the area seemed to reduce effectiveness, possibly because the nervous system’s response to the stimulus is part of the treatment.

A typical appointment runs like this. You lie face down or sit with your foot supported. The clinician locates the most tender spot, usually where the fascia anchors to the inner heel bone, marks it, applies ultrasound gel, and works the applicator over the area in slow passes while the device fires. Afterward, expect the heel to feel dull, warm, or mildly bruised for a day or two. You can usually walk out normally and return to daily activities immediately, though most providers advise easing off running and high-impact exercise for a short stretch around each session.

How long does shockwave therapy take to work?

Slower than anyone wants, and this is the single most common source of disappointment, so let’s set the clock honestly.

A standard course is three sessions, spaced about a week apart, though protocols range from one high-energy session to five or six lower-energy ones. Some people notice their morning first-step pain softening within days of the first session, likely from the nerve-modulating effect. But the trials measured their headline outcomes at around 12 weeks after treatment, and that’s when the real separation from sham appears. Tissue remodeling, new vessels, reorganized collagen, runs on a biological timetable measured in weeks and months, not appointments.

A realistic arc looks like this:

• Weeks 1–3 (during treatment): Temporary soreness after each session; some early flickers of relief, or none at all. Both are normal.
• Weeks 4–8: The window where most responders notice mornings improving and walking tolerance stretching out.
• Weeks 8–12 and beyond: Gains typically consolidate; follow-up studies suggest improvement can continue accruing for months.

Two implications follow. First, judging the treatment after one session is like judging a strength program after one gym visit: the mechanism hasn’t had time to work. Second, if you’ve reached the three-month mark with no change whatsoever, it’s fair to conclude you’re likely not a responder and to discuss next steps rather than buying another package. A trustworthy clinician will say the same.

"What finally cured my plantar fasciitis?", why that question misleads

Type that phrase into a search bar and you’ll find a thousand confident answers: a specific sandal, a stretching regimen, a $40 gadget, shockwave, dry needling, sheer time. Every one of those testimonials may be sincerely true for its author. Almost none of them transfer cleanly to you, and it’s worth understanding why.

Plantar fasciitis has a high natural recovery rate: the large majority of cases resolve within about 10 months regardless of which treatments were tried along the way. That creates a statistical trap: whatever someone happened to be doing in the month their heel finally turned the corner gets crowned as “the cure.” If they’d started shockwave that month, shockwave gets the credit. If they’d bought new shoes, the shoes get it. Researchers call this the natural-history fallacy, and it’s precisely why sham-controlled trials exist.

The condition is also not one disease. Heel pain can stem from fascia degeneration, a compressed nerve branch, a stress reaction in the heel bone, fat pad thinning, or tight calf muscles loading the fascia, and often several at once. A treatment that transforms one person’s heel may do nothing for a different underlying driver.

So the more useful question isn’t “what cured them?” but “what does the evidence show helps most people, and in what order?” On that question, the medical consensus is refreshingly boring: calf and fascia stretching, supportive footwear, activity modification, and patience form the foundation, with shockwave as a reasonable, evidence-backed escalation when months of the basics haven’t delivered.

How much does shockwave therapy for plantar fasciitis cost?

Here is where the evidence conversation collides with the checkbook, because in the United States shockwave therapy for plantar fasciitis is frequently paid out of pocket.

Many insurers classify ESWT for heel pain as investigational or not medically necessary, despite the FDA clearance and the trial literature, so coverage denials are common. Cash prices vary widely by region and device type: radial shockwave sessions at physical therapy or podiatry practices often run in the low-to-mid hundreds of dollars each, while focused shockwave, the pricier technology, can cost more per session. A full three-session course therefore commonly lands somewhere between several hundred and a couple of thousand dollars. Some practices bundle sessions into packages; read those carefully, since prepaying for six sessions of a treatment whose evidence base is built mostly on three deserves a raised eyebrow.

In the UK, the NHS notes that shockwave is available in some services for plantar fasciitis that hasn’t responded to other treatments, though access varies by area. Publicly funded systems generally position it exactly where the trials do: as a second-line option.

Before committing money, three questions are worth asking any provider: Is my case actually chronic (six months or more)? Have I genuinely exhausted the low-cost basics, daily stretching, footwear changes, load management, for at least a few months? And what is the total cost of the full recommended course, including any follow-up? If the answer to the second question is no, the cheapest effective treatment for your heel may still be sitting in the free tier.

Who is a good candidate, and who should skip it

The trials sketch a fairly clear portrait of the person most likely to benefit: an adult whose heel pain has persisted six months or longer, whose diagnosis of plantar fasciitis has been confirmed by a clinical exam (and imaging when the picture is unclear), and who has already given first-line care, stretching, supportive shoes, activity adjustments, an honest multi-month run. That’s the population the pivotal studies enrolled, and it’s where the 50-to-65-percent response figures come from.

Shockwave is generally not recommended, or requires case-by-case medical judgment, in several situations:

• Pregnancy, out of precaution regarding acoustic energy near the developing fetus.
• Bleeding disorders or medications that impair clotting, since the treatment causes controlled microtrauma and can bruise.
• Active infection, open wounds, or tumors in or near the treatment area.
• Adolescents with open growth plates near the heel.
• Certain implanted devices close to the treatment field, which warrant an individualized discussion.

Equally worth flagging: heel pain that isn’t plantar fasciitis. Burning pain, numbness, or tingling suggests a nerve problem; deep aching that worsens through the day with swelling can signal a bone stress injury. Aiming shockwave at the wrong diagnosis wastes money at best. This is one reason a proper evaluation beats booking directly off an ad: the exam that rules out mimics is arguably worth more than the treatment itself.

Side effects: what the safety data actually show

If shockwave has a genuinely strong suit, it’s safety. Across the randomized trials and the decades of clinical use since 2000, serious adverse events are rare: a track record that compares favorably with most of the alternatives further up the escalation ladder.

The common effects are local, mild, and short-lived:

• Soreness or aching in the heel for one to three days after a session
• Redness or minor swelling at the treatment site
• Small bruises, especially in people who bruise easily
• A temporary flare of the original pain before it settles
• Occasional transient numbness or tingling in the treated area

Rarer reports include small skin surface injuries at higher energy settings and, very uncommonly, more persistent pain. Rupture of the plantar fascia, a genuine concern with repeated injections into the heel, has not emerged as a meaningful risk in the shockwave literature, which is one of the treatment’s quiet advantages.

Context helps here. Every escalation option for stubborn plantar fasciitis carries trade-offs: injections can weaken tissue and thin the heel’s protective fat pad with repetition; surgery brings anesthesia, recovery time, and a small risk of destabilizing the foot’s arch. Against that backdrop, a treatment whose worst common outcome is a bruised, achy heel for a weekend occupies attractive territory, provided you go in understanding that “safe” and “guaranteed to work” are two different promises, and only the first one is on offer.

How shockwave compares with other plantar fasciitis treatments

No treatment for plantar fasciitis exists in a vacuum, so the fair question isn’t “does shockwave work?” but “does it work better than what I’d do instead?”

Against stretching and footwear changes, shockwave isn’t really a competitor: it’s an addition. Calf and plantar fascia stretching has solid trial support, costs nothing, and remains the foundation every guideline builds on. Studies that combined shockwave with a stretching program generally outperformed either alone.

Orthotics and heel supports, whether custom or off-the-shelf, offer modest evidence for symptom relief; interestingly, trials suggest prefabricated inserts often perform about as well as expensive custom ones for this condition.

Injections into the heel tend to win the sprint and lose the marathon: they often relieve pain faster than shockwave in the first month or two, but several comparative studies show shockwave catching up or pulling ahead by three to six months, without the tissue-weakening concerns that come with repeated injections.

Night splints hold the fascia stretched during sleep and help some people with severe morning pain, though comfort and adherence are their weak points.

Surgerypartially releasing the fascia, is the last resort, reserved for the small minority still in significant pain after a year or more of everything else. Its existence is, frankly, part of shockwave’s appeal: a moderately effective, low-risk middle step that helps a meaningful share of people avoid ever reaching the operating room is valuable even when it isn’t miraculous.

What to do alongside shockwave: this part matters more than the machine

Here’s an opinion the evidence supports: the people who get the most from shockwave treat it as one instrument in the orchestra, not the soloist. The trials that paired ESWT with a structured rehabilitation program consistently look better than device-only approaches, and the biology explains why, pressure waves may restart healing, but daily mechanics determine whether the repair holds.

Four habits carry most of the weight:

• Stretch the calf, not just the foot. Tight calf muscles transmit load straight into the plantar fascia. A wall stretch held 30 seconds, several times daily, plus a seated fascia stretch (pulling the toes back toward the shin) before that first morning step, targets the two biggest mechanical drivers.
• Manage load intelligently. This means trimming, not eliminating, the activities that flare the heel, then rebuilding gradually. Sudden increases in standing, walking, or running mileage are among the most common triggers in the first place.
• Audit your footwear. Worn-out soles, flat unsupportive flats, and barefoot time on hard floors all load the fascia. Cushioned, supportive shoes during the recovery window are unglamorous and effective.
• Strengthen the foot and calf. Progressive heel-raise exercises have promising evidence for building the fascia’s load tolerance over time.

None of this is exciting. All of it is cheap, evidence-aligned, and within your control, which is more than can be said for whether you land in the shockwave responder group. Stack the deck.

When to see a doctor about heel pain

Most heel pain can safely be managed at home for a few weeks. But certain patterns deserve a professional evaluation, some promptly, some urgently.

Make an appointment if:

• Heel pain hasn’t meaningfully improved after two to three weeks of rest, stretching, and supportive footwear
• Pain is severe enough to change how you walk, since limping breeds new problems in the knee, hip, and back
• You feel burning, numbness, or tingling in the heel or arch, signs the problem may be nerve-related rather than fascia-related
• Pain wakes you at night or aches at rest, which doesn’t fit the classic plantar fasciitis pattern
• You have diabetes and develop any new foot pain, because impaired sensation and circulation raise the stakes considerably

Seek care urgently if you cannot bear weight on the foot, if the heel is swollen, hot, or red alongside a fever (possible infection), or if you felt a sudden pop followed by sharp pain and bruising, which can signal a fascia tear.

There’s a second, less dramatic reason to get evaluated before pursuing shockwave: the diagnosis itself. Studies of chronic heel pain consistently find look-alike conditions, nerve entrapment, bone stress injuries, fat pad problems, inflammatory arthritis, hiding under the plantar fasciitis label. Every one of those calls for a different plan, and no number of acoustic pulses will fix a misdiagnosis. A careful exam is the least expensive high-value step in this entire article.

So, should you try it? An honest verdict

Judged strictly on the trial record, shockwave therapy for plantar fasciitis earns a qualified yes, and the qualifications are exactly where the value lies.

The case for: multiple randomized, sham-controlled trials and pooled analyses show real benefit for chronic heel pain, roughly half to two-thirds of patients respond meaningfully, gains appear durable at one to two years in follow-up studies, and the safety profile is about as gentle as interventions get. For the person six-plus months into this ordeal who has genuinely worked the basics, it’s a rational next step with better evidence than most of what’s sold for foot pain.

The case for restraint: the effect size is moderate, not transformative; a substantial minority of patients get little or nothing; protocols vary enough that your results may not match the trials; and the out-of-pocket cost is real. Anyone promising a fix in one session is selling past the evidence.

If a decision rule helps, try this one. Under three months of heel pain? Spend your energy, and almost no money, on stretching, footwear, and load management, because time is heavily on your side. Past the six-month mark with a confirmed diagnosis and diligent conservative care behind you? Shockwave is a reasonable, evidence-supported bet, entered with three sessions, twelve weeks of patience, and a pre-agreed exit point if nothing changes. That’s not a miracle story. It’s something better: a treatment whose honest description still makes it worth considering.

Frequently asked questions

Does shockwave therapy for plantar fasciitis really work?

For chronic cases, the evidence says probably yes. Randomized sham-controlled trials and meta-analyses show shockwave relieves heel pain better than placebo at around three months, with roughly half to two-thirds of patients meaningfully improved. It has not been well studied for recent-onset heel pain, and a substantial minority of treated patients see little benefit, so it works best as a second-line option after months of stretching and footwear changes.

How long does shockwave therapy take to heal plantar fasciitis?

Expect a slow build, not a switch. Treatment itself usually spans three weekly sessions, but the trials measured their main benefits about 12 weeks after finishing, because the tissue repair the therapy aims to trigger takes weeks to months. Some people notice softer morning pain within days; most responders see clear improvement between weeks four and twelve. If nothing has changed by three months, you are likely not a responder.

How many shockwave sessions do I need for plantar fasciitis?

Three sessions spaced about a week apart is the most common evidence-based protocol, typically delivering around 2,000 pulses per visit. Some clinicians use a single higher-energy session or extend to five or six lower-energy ones; trials haven’t crowned one schedule as clearly best. Be cautious about prepaying for long packages: the core research was built mostly on short courses, and more sessions haven’t been shown to rescue non-responders.

How much does shockwave therapy for plantar fasciitis cost?

In the United States, sessions commonly cost a few hundred dollars each out of pocket, so a standard three-session course often totals several hundred to a couple of thousand dollars, with focused devices generally pricier than radial ones. Many insurers consider ESWT for heel pain investigational and deny coverage, so confirm benefits before booking. In the UK, the NHS offers it in some services when other treatments have failed.

Does shockwave therapy hurt?

It’s uncomfortable but tolerable for most people: a rapid, deep tapping or snapping sensation over the tender heel for 15 to 20 minutes. Clinicians start at lower energy and increase to your tolerance, and sessions typically feel easier as the heel improves. Most protocols avoid numbing injections, partly because studies suggest anesthetizing the area may reduce the treatment’s effectiveness. Expect a bruised, achy feeling for a day or two afterward.

What is the success rate of shockwave therapy for plantar fasciitis?

Across randomized trials, roughly 50 to 65 percent of patients with chronic plantar fasciitis achieve a clinically meaningful reduction in pain, compared with about 30 to 45 percent receiving sham treatment. That gap is real but moderate. Success rates vary with device type, energy settings, and how chronic and well-diagnosed the case is. Follow-up studies suggest responders usually maintain their improvement at one to two years.

Can shockwave therapy make plantar fasciitis worse?

A temporary flare is common and usually settles within a few days, soreness, redness, minor bruising, and occasionally brief numbness or tingling are the expected effects of the controlled microtrauma the treatment creates. Lasting worsening is rare in the trial literature, and plantar fascia rupture has not emerged as a meaningful shockwave risk. People with bleeding disorders, active infection at the site, or certain other conditions should avoid it.

Is focused or radial shockwave better for plantar fasciitis?

Neither has proven clearly superior for heel pain. Focused shockwave delivers a true, deep-penetrating pulse and underlies much of the original trial evidence; radial devices produce a shallower pressure wave, cost less, and are more widely available. Both beat sham in studies, and some analyses hint focused may have an edge for deep attachments like the plantar fascia. Operator skill and correct diagnosis likely matter more than the machine.

Who should not get shockwave therapy?

Shockwave is generally avoided during pregnancy, in people with bleeding disorders or medications that impair clotting, over areas with active infection, open wounds, or tumors, and in adolescents with open growth plates near the heel. Certain implanted devices near the treatment field warrant individualized medical judgment. It’s also inappropriate when heel pain stems from something other than plantar fasciitis: a nerve problem or bone stress injury needs a different plan entirely.

What finally cures plantar fasciitis?

No single treatment cures it for everyone, and most ‘this fixed me’ stories reflect timing: about 90 percent of cases resolve within roughly 10 months, so whatever someone tried last gets the credit. The evidence-backed foundation is calf and fascia stretching, supportive footwear, activity modification, and gradual strengthening. Shockwave, night splints, orthotics, and injections are reasonable escalations for stubborn cases, with surgery reserved for the small minority still suffering after a year or more.

References

• Cleveland Clinic: Plantar Fasciitis
• NHS: Plantar fasciitis
• MedlinePlus: Plantar fasciitis

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.